124 related articles for article (PubMed ID: 36507595)
21. Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression.
Yang C; Yang J; Sun M; Yan J; Meng X; Ma T
IUBMB Life; 2013 May; 65(5):435-44. PubMed ID: 23441067
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS.
Cao P; Xia Y; He W; Zhang T; Hong L; Zheng P; Shen X; Liang G; Cui R; Zou P
Int J Biol Sci; 2019; 15(8):1676-1684. PubMed ID: 31360110
[TBL] [Abstract][Full Text] [Related]
23. Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.
Nakatani K; Maehama T; Nishio M; Otani J; Yamaguchi K; Fukumoto M; Hikasa H; Hagiwara S; Nishina H; Mak TW; Honma T; Kondoh Y; Osada H; Yoshida M; Suzuki A
Cancer Sci; 2021 Oct; 112(10):4303-4316. PubMed ID: 34289205
[TBL] [Abstract][Full Text] [Related]
24. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
25. Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone.
Rasul A; Khan M; Ali M; Li J; Li X
ScientificWorldJournal; 2013; 2013():248532. PubMed ID: 24288468
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Alantolactone on Proliferation of RPMI-8226 Cells and Its Possible Mechnism].
Yao Y; Sun YY; Xia DD; Niu MS; Zhao K; Li ZY; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1336-40. PubMed ID: 26524033
[TBL] [Abstract][Full Text] [Related]
27. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells.
Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J
Biochem Pharmacol; 2016 Feb; 102():34-44. PubMed ID: 26686580
[TBL] [Abstract][Full Text] [Related]
29. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
[TBL] [Abstract][Full Text] [Related]
30. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells.
Chun J; Choi RJ; Khan S; Lee DS; Kim YC; Nam YJ; Lee DU; Kim YS
Int Immunopharmacol; 2012 Dec; 14(4):375-83. PubMed ID: 22940184
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma.
Wang Y; Yu RY; Zhang J; Zhang WX; Huang ZH; Hu HF; Li YL; Li B; He QY
Biochem Pharmacol; 2017 Apr; 129():43-53. PubMed ID: 28104435
[TBL] [Abstract][Full Text] [Related]
32. 2α-Hydroxyeudesma-4,11(13)-Dien-8β,12-Olide Isolated from
Jang DK; Lee IS; Shin HS; Yoo HM
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32085513
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive review of anticancer mechanisms of action of Alantolactone.
Babaei G; Gholizadeh-Ghaleh Aziz S; Rajabi Bazl M; Khadem Ansari MH
Biomed Pharmacother; 2021 Apr; 136():111231. PubMed ID: 33454597
[TBL] [Abstract][Full Text] [Related]
34. Alantolactone induces activation of apoptosis in human hepatoma cells.
Lei JC; Yu JQ; Yin Y; Liu YW; Zou GL
Food Chem Toxicol; 2012 Sep; 50(9):3313-9. PubMed ID: 22721982
[TBL] [Abstract][Full Text] [Related]
35. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species.
Kitano Y; Baba Y; Nakagawa S; Miyake K; Iwatsuki M; Ishimoto T; Yamashita YI; Yoshida N; Watanabe M; Nakao M; Baba H
J Pathol; 2018 Mar; 244(3):346-357. PubMed ID: 29243822
[TBL] [Abstract][Full Text] [Related]
36. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.
Ren Y; Lv C; Zhang J; Zhang B; Yue B; Luo X; Yu Z; Wang H; Ren J; Wang Z; Dou W
Mol Cell Biochem; 2021 Dec; 476(12):4387-4403. PubMed ID: 34460036
[TBL] [Abstract][Full Text] [Related]
37. Alantolactone induces apoptosis in THP-1 cells through STAT3, survivin inhibition, and intrinsic apoptosis pathway.
Ahmad B; Gamallat Y; Su P; Husain A; Rehman AU; Zaky MY; Bakheet AMH; Tahir N; Xin Y; Liang W
Chem Biol Drug Des; 2021 Feb; 97(2):266-272. PubMed ID: 32780548
[TBL] [Abstract][Full Text] [Related]
38. Semisynthesis, an Anti-Inflammatory Effect of Derivatives of 1β-Hydroxy Alantolactone from Inula britannica.
Chen L; Zhang JP; Liu X; Tang JJ; Xiang P; Ma XM
Molecules; 2017 Oct; 22(11):. PubMed ID: 29077042
[TBL] [Abstract][Full Text] [Related]
39. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
Yao Y; Xia D; Bian Y; Sun Y; Zhu F; Pan B; Niu M; Zhao K; Wu Q; Qiao J; Fu C; Li Z; Xu K
Apoptosis; 2015 Aug; 20(8):1122-33. PubMed ID: 26033479
[TBL] [Abstract][Full Text] [Related]
40. Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling.
Liu YR; Cai QY; Gao YG; Luan X; Guan YY; Lu Q; Sun P; Zhao M; Fang C
Phytother Res; 2018 Apr; 32(4):643-650. PubMed ID: 29210118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
